average weekly weight loss on tirzepatide reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 How Much Weight Will I

The comprehensive case for GLP1 skepticism, w/ @RobertLustigMD open.spotify.com/episode/0EMivI The bull case for GLP1s as a societal revolution, in brief 1: Obesity affects 100m+ ppl but is under-treated without safe, effective, lasting, high-adherence interventions

Suppressing Glucagon Release: It reduces the secretion of glucagon, another hormone that raises blood sugar, further contributing to glucose control

and M.M.C

Further exploration of these modified agents in animal models of cardiometabolic diseases will deepen our understanding of the potential cardioprotective mechanisms of GLP-1 and GLP-1RAs and potentially provide future directions for precise therapeutic intervention [180]